Envista Holdings Corp
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Paul A. Keel
- Full Time Employees
- 12,000
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- Building E Brea CA United States of America 92821-6208
- IPO Date
- Sep 18, 2019
- CIK
- 0001757073
- Website
- envistaco.com
- Similar Companies
- Business
- Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.
Company News
Envista Holdings Corporation (NYSE:NVST) Stock Rated “Hold” by Wall Street Brokerages
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Here's Why Envista (NVST) is a Strong Growth Stock
Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?
Envista Schedules Third Quarter 2026 Earnings Call
New Strong Buy Stocks for September 28th
NVST vs. ABT: Which Stock Is the Better Value Option?
Best Value Stocks to Buy for September 21st
Should Value Investors Buy Envista (NVST) Stock?
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Here's Why Envista (NVST) is a Strong Value Stock
Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript
NVST or ABT: Which Is the Better Value Stock Right Now?
Envista Announces Participation in Baird 2026 Global Healthcare Conference
Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
Canada Pension Plan Investment Board Takes Position in Envista Holdings Corporation $NVST
4 PEG-Based Value Stocks to Buy as Investors Look Beyond AI
Best Momentum Stocks to Buy for August 27th